02:05:13 EDT Sun 19 May 2024
Enter Symbol
or Name
USA
CA



Newtopia Inc
Symbol NEWU
Shares Issued 156,826,621
Close 2023-11-09 C$ 0.09
Market Cap C$ 14,114,396
Recent Sedar Documents

Newtopia to release Q3 results, host call Nov. 16

2023-11-09 16:48 ET - News Release

An anonymous director reports

NEWTOPIA SCHEDULES THIRD QUARTER 2023 EARNINGS RELEASE AND CONFERENCE CALL

Newtopia Inc. will release its financial results for the quarter ended Sept. 30, 2023, after market close on Thursday, Nov. 16, 2023. The company will also host a conference call that day at 5 p.m. Eastern Time to discuss the third quarter 2023 results in further detail.

To listen to the conference call, please dial 877-407-3982 (United States) or 201-493-6780 (international) 10 minutes prior to the start time. The call will also be available by live webcast in the investor relations portion of the company's website.

If you cannot listen to the conference call at its scheduled time, there will be a replay available through Thursday, Dec. 7, 2023, by dialling 844-512-2921 (United States) or 412-317-6671 (international) and entering the passcode 13741435. The webcast will also be archived on the company's website.

About Newtopia Inc.

Newtopia is a technology-enabled whole health platform, helping people create positive lifelong habits that prevent, slow or reverse chronic disease while reducing health care costs. The platform leverages genetic, social and behavioural insights to create individualized prevention programs with a focus on metabolic disease, diabetes, mental health challenges, hypertension, weight management and musculoskeletal disorders. With a person-centred approach that combines virtual care, digital tools, connected devices and actionable data science, Newtopia delivers sustainable clinical and financial outcomes. Newtopia serves some of the largest nationwide employers and health plans, is currently listed in Canada on the TSX Venture Exchange (NEWU), and is quoted in the United States on the OTCQB Venture Market (NEWUF).

© 2024 Canjex Publishing Ltd. All rights reserved.